• MJHLS Brand Logo

© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Don’t sweat the holidays: Top 4 hyperhidrosis stories

December 17, 2018
Dermatology Times Staff

We've gathered our latest and greatest articles on excessive sweating so you can sit back and relax over the holiday. From a new topical to Botox to treatments yet to come, our slideshow contains all you need to know about novel hyperhidrosis treatments.

Don't sweat this holiday season. We've gathered our latest and greatest articles on excessive sweating so you can sit back and relax over the holiday. From a new topical to Botox to treatments yet to come, our slideshow contains all you need to know about novel hyperhidrosis treatments.

FDA APPROVES TREATMENT FOR UNDERARM SWEATING: The FDA approved Qbrexza (glycopyrronium) for primary axillary hyperhidrosis earlier this year. The first FDA-approved once-daily topical for this condition, Qbrexza is an anticholinergic that comes as a cloth designed to inhibit the activation of sweat glands. (©PopPaulCatalin - stock.adobe.com)

UNCOVERING THE CAUSE OF ARMPIT IRRITATION: What causes underarm irritation and how can it be avoided? Find out in this article. (franz12 - stock.adobe.com)

HYPERHIDROSIS EXPERT COMPARES TODAY'S TREATMENT OPTIONS: With the FDA’s approval of the first topical hyperhidrosis treatment in June this year, physicians treating excessive underarm sweating can offer patients a range of approved options, including Botox, MiraDry and soon Qbrexa. Dee Anna Glaser, M.D. discusses these options in this article. (Denys Kurbatov - stock.adobe.com)

MORE NEW THERAPIES UNDER STUDY FOR UNDERARM SWEAT: David M. Pariser, M.D., FAAD, secretary and founding president of the International Hyperhidrosis Society, highlights the latest research and treatments for primary axillary hyperhidrosis. (glisic albina - stock.adobe.com)

PreviousNext